Results 231 to 240 of about 261,610 (341)
Current Application Status and Innovative Development of Surgical Robot
Advantage, Challenge and Innovation of surgical robots. ABSTRACT Surgery has undergone a revolutionary development since the innovations in anesthesiology, aseptic techniques, and antibiotics. The use of modern techniques, especially minimally invasive techniques, has led to a new era of microsurgery and reduced patient trauma.
Aimin Jiang +11 more
wiley +1 more source
Spontaneous lumbar epidural hematoma induced by acute disc herniation: A rare cause of cauda equina syndrome successfully treated with minimally invasive surgery - A case report. [PDF]
Obeidat BO, Altunbi B, Jaradat F.
europepmc +1 more source
Evacuation with Subcutaneous Puncture of Particular Extradural Hematoma in Infancy
Hideo Aoki
openalex +2 more sources
This study evaluated the safety and efficacy of the Zenith fenestrated endovascular graft for treating juxtarenal abdominal aortic aneurysms (JRAAs) in a Chinese patient population. The results demonstrated the high technical success rates, low mortality, and acceptable morbidity.
Xiaohui Ma +9 more
wiley +1 more source
Quantification of hounsfield unit difference in heterogeneous hematoma predicts poor functional outcomes in acute intracerebral hemorrhage. [PDF]
Wu Q +7 more
europepmc +1 more source
Durability of Quality‐of‐Life Improvements Following Pediatric Septorhinoplasty
Abstract Objective To assess the durability of improvements in validated quality‐of‐life measures in children undergoing septoplasty and septorhinoplasty. Study Design Prospective enrollment of consecutive patients undergoing evaluation for surgery. Setting Academic, free‐standing children's hospital.
Ethan Frank +3 more
wiley +1 more source
Subdural and epi-arachnoid hemorrhage following spinal epidural block requiring hematoma removal: illustrative case. [PDF]
Han SY, Se SU, Jang JW, Cho YE, Park CK.
europepmc +1 more source
Hemophilia A: An Ideal Disease for Prenatal Therapy
ABSTRACT Hemophilia A (HA) is the most common inherited coagulation defect. Current state‐of‐the‐art treatment consists of frequent administration of prophylactic infusions of coagulation factor VIII (FVIII) protein or bispecific antibodies that replace the cofactor function of FVIIIa to maintain hemostasis. However, these treatments are far from ideal,
Christopher D. Porada +2 more
wiley +1 more source

